Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to generate long-term safety, tolerability and efficacy data for
AFQ056 in patients who have participated in and completed any AFQ056 phase II study in PD-LID
(Parkinson's disease, L-dopa induced dyskinesias).